Title (fr)

Publication

Application

Priority

US 2008004997 W 20080417

US 92543207 P 20070420

US 95333007 P 20070801

Abstract (en)

[origin: WO2008130615A1] The present invention relates to methods of using Tetrahydropyrido[4,3-d]Pyrimidinone Derivatives for treating or preventing obesity, diabetes, a metabolic disorder, a cardiovascular disease or a disorder related to the activity of GPR119 in a patient.